论文部分内容阅读
为了较真实地反应人体内免疫系统对肝癌抗原的免疫应答，我们选择了ＳＣＩＤ小鼠作为模型。实验选择４～１２周龄ＳＣＩＤ小鼠（免疫缺陷特性稳定），用人胎肝和胸腺细胞悬液（２×１０７／只）经腹腔注射途径及用适量（５００Ｕ／只）ＩＬ－２诱导，对其进行了免疫重建。...
In order to more accurately reflect the immune response of the human immune system to liver cancer antigens, we chose SCID mice as a model. 4-12 week old SCID mice (stability of immunodeficiency) were selected for the experiment and were induced by intraperitoneal injection of human fetal liver and thymus cell suspension (2×107/mouse) and with appropriate amount (500 U/only) of IL-2. It was immune reconstituted. ...